Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2007

View Archived Issues

Recent patents disclose novel analgesic agents

New treatments for cancer described in recent patents

Snapshots from the European Winter Conference on Brain Research

OxyADF is aversive in subjects with history of opioid abuse

Emergent to use VaxImmune in development of new anthrax vaccines

FDA extends review period for Frova menstrual migraine sNDA

Clearance for Spanish trial of P-144 for scleroderma

Enrollment completed in phase II trials for Amigal

Sanofi-aventis planning European launch of SoloSTAR disposable insulin pen

Trans-sodium crocetinate begins clinical testing

Neuroprotective effects of herbal medicines

Zolpidem improves motor, cognition performance in a patient with akinetic mutism

Sildenafil improves exercise capacity in idiopathic pulmonary fibrosis

Herpes simplex virus shows potential as a diagnostic tool for cancer

Tyrosine kinase inhibitors delay tumor growth in ocular melanoma model

Celecoxib reduces PanIN lesions and papilloma formation in a pancreatic cancer model

Cancer-associated pathways modulated by (S)-HDAC-42

Spectrum updates clinical progress of 2006

New targets for neurodegenerative diseases

Japanese launch for Certican tablets

Lialda now available

EGFR intron 1 status predicts sensitivity to erlotinib in pancreatic cancer cells

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...